Skip to main content

Table 3 Outcomes (intention-to-treat)

From: Economic evaluation of an experience sampling method intervention in depression compared with treatment as usual using data from a randomized controlled trial

 

ESM-I (n = 33)

Pseudo-intervention (n = 35)

Control (n = 33)

Regression coefficients; B (95% confidence interval)a

ESM-I vs Control

ESM-I vs Pseudo-intervention

HDRS (at 32 weeks)

 HDRS scorea

10.8 (7.1)

13 (7.12)

15.3 (8.3)

−3.1 (−6.2; 0.01)

−1.13 (−4.18; 1.92)

 Improvement since baseline

2.7 (6.1)

2.1 (5.9)

0.24 (7.5)

3.1 (−0.01; 6.2)

1.13 (−1.92; 4.18)

 Symptomatic remissionb

11 (33.3)

9 (25.7)

6 (18.2)

OR = 2.65 (0.79; 8.9)

OR = 1.84 (0.59; 5.7)

QALYs (over 32 weeks)

 EQ-5D, UK tariff

0.45 (0.17)

0.38 (0.18)

0.32 (0.18)

0.08 (0.02; 0.10)*

0.04 (−0.02; 0.10)

  1. HDRS 17-item Hamilton Depression Rating Scale, QALY quality adjusted life year, EQ-5D EuroQol-5D-3L
  2. *p < 0.05
  3. aControlled for baseline values
  4. bSymptomatic remission = HDRS score ≤ 7